Pharma companies settle bowel disease drug dispute
Pharmaceutical companies from Canada and Italy have agreed to settle a US$365 million ICC dispute over the development of a drug used in the treatment of inflammatory bowel disease.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10